| Literature DB >> 28435527 |
Li Li1,2, Xian Jiang2, Shaoqiang Huang2, Zhengxin Ying2, Zhaolan Zhang2, Chenjie Pan2, Sisi Li2, Xiaodong Wang2, Zhiyuan Zhang2,3.
Abstract
A series of 2-sulfonyl-pyrimidinyl derivatives was developed as apoptosis inhibitors. These represent the first class of apoptosis inhibitors that function through stabilizing mitochondrial respiratory complex II. Starting from a phenotypic screen hit with micromolar activity, we optimized the cellular apoptosis inhibition activity of 2-sulfonyl-pyrimidinyl derivatives to picomolar level (compound 42, also named as TC9-305). The therapeutic potential of these new apoptosis inhibitors was further demonstrated by their neuroprotective effect on an ischemic animal model.Entities:
Keywords: Apoptosis inhibitors; ischemia treatment; mitochondria protection; phenotypic screen; structure−activity optimization
Year: 2017 PMID: 28435527 PMCID: PMC5392758 DOI: 10.1021/acsmedchemlett.6b00489
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345